A case of lipoatrophy following quadrivalent human papillomavirus vaccine administration.
Department of Dermatology, Hotel Dieu de France University Hospital, Beirut, Lebanon - Faculty of Medicine, Saint Joseph University, Beirut, Lebanon.
Farid
F
Stéphan
Department of Dermatology, Hotel Dieu de France University Hospital, Beirut, Lebanon - Faculty of Medicine, Saint Joseph University, Beirut, Lebanon. Electronic address: joelle.korkomaz@usj.edu.lb.
Joelle
J
Korkomaz
Department of Pathology, Hotel Dieu de France University Hospital, Beirut, Lebanon - Faculty of Medicine, Saint Joseph University, Beirut, Lebanon.
Gerard
G
Abadjian
Department of Rhumatology, Hotel Dieu de France University Hospital, Beirut, Lebanon - Faculty of Medicine, Saint Joseph University, Beirut, Lebanon.
Jad
J
Okais
Department of Dermatology, Hotel Dieu de France University Hospital, Beirut, Lebanon - Faculty of Medicine, Saint Joseph University, Beirut, Lebanon.
Roland
R
Tomb
D000328:Adult; D001707:Biopsy, Needle; D005260:Female; D000068857:Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18; D052162:Human papillomavirus 16 / Q000276:immunology*; D006801:Humans; D007150:Immunohistochemistry; D007273:Injections, Intramuscular; D008060:Lipodystrophy / Q000139:chemically induced* / Q000473:pathology; D030361:Papillomavirus Infections / Q000517:prevention & control*; D053918:Papillomavirus Vaccines / Q000009:adverse effects*; D035583:Rare Diseases; D018570:Risk Assessment; D002583:Uterine Cervical Neoplasms / Q000517:prevention & control*
D000068857:Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18; D053918:Papillomavirus Vaccines